| Joseph J Dorchak, MD | |
|
700 Village Dr, Fairmont, WV 26554-7985 | |
| (304) 366-2600 | |
| Not Available |
| Full Name | Joseph J Dorchak |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 24 Years |
| Location | 700 Village Dr, Fairmont, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801846399 | NPI | - | NPPES |
| 3810005534 | Medicaid | WV | |
| P00323099 | Other | WV | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 21961 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| United Hospital Center | Bridgeport, WV | Hospital |
| Davis Medical Center | Elkins, WV | Hospital |
| Summersville Regional Medical Center | Summersville, WV | Hospital |
| Mon Health Medical Center | Morgantown, WV | Hospital |
| Berkeley Medical Center | Martinsburg, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Radiological Physician Associates Inc | 7719955368 | 29 |
News Archive
In a recent breakthrough to combat malaria, a collaboration of Indian and American scientists have identified a malarial parasite protein that can be used to develop antibodies when displayed on novel nanoparticles. This approach has the potential to prevent the parasite from multiplying in the human host and also inhibits transmission through mosquitoes. The finding points towards developing a powerful malaria vaccine in the hope of eradicating this debilitating and often fatal disease.
Research Down Syndrome has launched an international outreach program to focus awareness and support for the rapidly advancing area of biomedical research leading to safe and effective approved medical therapies to treat cognitive impairment in individuals of all ages with Down syndrome - improving memory, learning and communication.
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, announced today that the underwriters of its previously announced public offering of common stock have exercised in full their option to purchase 1,350,000 shares of common stock at a public offering price of $8.00 per share.
The National Institutes of Health (NIH) in the USA are to conduct a large-scale clinical trial to evaluate a new fully-human polyclonal antibody therapy targeted at severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19).
› Verified 6 days ago
| Entity Name | Pendleton Community Care Inc |
|---|---|
| Entity Type | Part B Supplier - Public Health/welfare Agency |
| Entity Identifiers | NPI Number: 1265634059 PECOS PAC ID: 3678470614 Enrollment ID: O20031217000523 |
News Archive
In a recent breakthrough to combat malaria, a collaboration of Indian and American scientists have identified a malarial parasite protein that can be used to develop antibodies when displayed on novel nanoparticles. This approach has the potential to prevent the parasite from multiplying in the human host and also inhibits transmission through mosquitoes. The finding points towards developing a powerful malaria vaccine in the hope of eradicating this debilitating and often fatal disease.
Research Down Syndrome has launched an international outreach program to focus awareness and support for the rapidly advancing area of biomedical research leading to safe and effective approved medical therapies to treat cognitive impairment in individuals of all ages with Down syndrome - improving memory, learning and communication.
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, announced today that the underwriters of its previously announced public offering of common stock have exercised in full their option to purchase 1,350,000 shares of common stock at a public offering price of $8.00 per share.
The National Institutes of Health (NIH) in the USA are to conduct a large-scale clinical trial to evaluate a new fully-human polyclonal antibody therapy targeted at severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19).
› Verified 6 days ago
| Entity Name | Radiological Physician Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811996960 PECOS PAC ID: 7719955368 Enrollment ID: O20040921000855 |
News Archive
In a recent breakthrough to combat malaria, a collaboration of Indian and American scientists have identified a malarial parasite protein that can be used to develop antibodies when displayed on novel nanoparticles. This approach has the potential to prevent the parasite from multiplying in the human host and also inhibits transmission through mosquitoes. The finding points towards developing a powerful malaria vaccine in the hope of eradicating this debilitating and often fatal disease.
Research Down Syndrome has launched an international outreach program to focus awareness and support for the rapidly advancing area of biomedical research leading to safe and effective approved medical therapies to treat cognitive impairment in individuals of all ages with Down syndrome - improving memory, learning and communication.
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, announced today that the underwriters of its previously announced public offering of common stock have exercised in full their option to purchase 1,350,000 shares of common stock at a public offering price of $8.00 per share.
The National Institutes of Health (NIH) in the USA are to conduct a large-scale clinical trial to evaluate a new fully-human polyclonal antibody therapy targeted at severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19).
› Verified 6 days ago
| Entity Name | Premier Imaging And Intervention Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285633370 PECOS PAC ID: 4587562335 Enrollment ID: O20050617000389 |
News Archive
In a recent breakthrough to combat malaria, a collaboration of Indian and American scientists have identified a malarial parasite protein that can be used to develop antibodies when displayed on novel nanoparticles. This approach has the potential to prevent the parasite from multiplying in the human host and also inhibits transmission through mosquitoes. The finding points towards developing a powerful malaria vaccine in the hope of eradicating this debilitating and often fatal disease.
Research Down Syndrome has launched an international outreach program to focus awareness and support for the rapidly advancing area of biomedical research leading to safe and effective approved medical therapies to treat cognitive impairment in individuals of all ages with Down syndrome - improving memory, learning and communication.
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, announced today that the underwriters of its previously announced public offering of common stock have exercised in full their option to purchase 1,350,000 shares of common stock at a public offering price of $8.00 per share.
The National Institutes of Health (NIH) in the USA are to conduct a large-scale clinical trial to evaluate a new fully-human polyclonal antibody therapy targeted at severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph J Dorchak, MD Po Box 890707, Charlotte, NC 28289-0707 Ph: (866) 338-6463 | Joseph J Dorchak, MD 700 Village Dr, Fairmont, WV 26554-7985 Ph: (304) 366-2600 |
News Archive
In a recent breakthrough to combat malaria, a collaboration of Indian and American scientists have identified a malarial parasite protein that can be used to develop antibodies when displayed on novel nanoparticles. This approach has the potential to prevent the parasite from multiplying in the human host and also inhibits transmission through mosquitoes. The finding points towards developing a powerful malaria vaccine in the hope of eradicating this debilitating and often fatal disease.
Research Down Syndrome has launched an international outreach program to focus awareness and support for the rapidly advancing area of biomedical research leading to safe and effective approved medical therapies to treat cognitive impairment in individuals of all ages with Down syndrome - improving memory, learning and communication.
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, announced today that the underwriters of its previously announced public offering of common stock have exercised in full their option to purchase 1,350,000 shares of common stock at a public offering price of $8.00 per share.
The National Institutes of Health (NIH) in the USA are to conduct a large-scale clinical trial to evaluate a new fully-human polyclonal antibody therapy targeted at severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19).
› Verified 6 days ago
Deborah A Willard, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 700 Village Dr, Fairmont, WV 26554 Phone: 304-366-2600 | |
Gerardo M Lopez, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 700 Village Dr, Fairmont, WV 26554 Phone: 304-366-2600 | |
Dr. Roberto A Cunanan, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1322 Locust Ave, Fairmont, WV 26554 Phone: 304-366-0700 Fax: 304-366-9529 | |
James A Ross, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 700 Village Dr, Fairmont, WV 26554 Phone: 304-366-2600 | |
Dr. Mark A Hackney, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 700 Village Dr, Fairmont, WV 26554 Phone: 304-366-2600 Fax: 304-366-2080 | |
Claudia A Goodwin, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 700 Village Dr, Fairmont, WV 26554 Phone: 304-366-2600 | |
John A Leon, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 700 Village Dr, Fairmont, WV 26554 Phone: 304-366-2600 |